Pemetrexed-induced edema of the eyelid

Lung Cancer

Volumn 54, Issue 2, 2006, Pages 241-242

  Kurata, Takayasu ^a   Tamura, Kenji ^a   Okamoto, Isamu ^a   Satoh, Taroh ^a   Nakagawa, Kazuhiko ^a   Fukuoka, Masahiro ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Eyelid edema; Lung cancer; Supportive care

Indexed keywords

CISPLATIN; DEXAMETHASONE; GEFITINIB; GEMCITABINE; PEMETREXED;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; BRAIN METASTASIS; CASE REPORT; DRUG INDUCED DISEASE; EYELID EDEMA; HUMAN; LUNG ADENOCARCINOMA; LUNG METASTASIS; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; DEXAMETHASONE; EDEMA; EYELID DISEASES; EYELIDS; GLUTAMATES; GUANINE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 33751096509     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.08.002     Document Type: Article

References (5)

1. Hanna N., Shepherd F.A., Fossella F.V., Pereira J.R., De Marinis F., Von Pawel J., et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small cell lung cancer previously treated with chemotherapy. J Clin Oncol 22 (2004) 1589-1597
2. Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (2003) 2636-2644
3. Niyikiza C., Baker S.D., Seitz D.E., Walling J.M., Nelson K., Rusthoven J.J., et al. Homocysteine and methylmalonic acid: Markers to predict and avoid toxicity from pemetrexed therapy. Mol Cancer Ther 1 (2002) 545-552
4. 12 in Japanese patients with solid tumors. Presented at the 16th EORTC-NCI-AACR, Geneva, Switzerland, September 28-October 1, 2004.
5. Semb K.A., Aamdal S., and Oian P. Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol 16 (1998) 3426-3432